Taxane chemotherapy induces stromal injury that leads to breast cancer dormancy escape.
Saved in:
| Title: | Taxane chemotherapy induces stromal injury that leads to breast cancer dormancy escape. |
|---|---|
| Authors: | Ganesan R; Department of Medicine-Renal Division, Emory University School of Medicine, Atlanta, Georgia, United States of America., Bhasin SS; Department of Pediatrics-Hematology Division, Emory University School of Medicine, Atlanta, Georgia, United States of America.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, United States of America., Bakhtiary M; Department of Pediatrics-Hematology Division, Emory University School of Medicine, Atlanta, Georgia, United States of America.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, United States of America., Krishnan U; Department of Pediatrics-Hematology Division, Emory University School of Medicine, Atlanta, Georgia, United States of America.; Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia, United States of America., Cheemarla NR; Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America., Thomas BE; Department of Pediatrics-Hematology Division, Emory University School of Medicine, Atlanta, Georgia, United States of America.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, United States of America., Bhasin MK; Department of Pediatrics-Hematology Division, Emory University School of Medicine, Atlanta, Georgia, United States of America.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, United States of America.; Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia, United States of America.; Department of Biomedical Informatics, Emory University, Atlanta, Georgia, United States of America.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, United States of America.; Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America., Sukhatme VP; Department of Medicine-Renal Division, Emory University School of Medicine, Atlanta, Georgia, United States of America.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, United States of America.; Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America. |
| Source: | PLoS biology [PLoS Biol] 2023 Sep 12; Vol. 21 (9), pp. e3002275. Date of Electronic Publication: 2023 Sep 12 (Print Publication: 2023). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101183755 Publication Model: eCollection Cited Medium: Internet ISSN: 1545-7885 (Electronic) Linking ISSN: 15449173 NLM ISO Abbreviation: PLoS Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
